Innovating Works

SYSTASY BIOSCIENCE GMBH

Desconocido
PSY-PGx: A New Intervention for Implementation of Pharmacogenetics in Psychiatry SYSTASY BIOSCIENCE GMBH participó en un H2020: H2020-SC1-BHC-2018-2020 Due to the chronic relapsing nature of mental disorders and increased life expectancy, the societal burden of these non-communicable disease...
2021-02-01 - 2026-02-28 | Financiado
SZ_TEST: Towards Early Molecular Diagnostics of Schizophrenia SYSTASY BIOSCIENCE GMBH participó en un H2020: H2020-MSCA-RISE-2016 Schizophrenia (SZ) is a severe mental disorder affecting more than 0.7% of the adult population. One of the most disabling and emotionally d...
2016-12-05 - 2022-06-30 | Financiado
PDZnet: Unraveling Principles of PDZ mediated Cell Signaling SYSTASY BIOSCIENCE GMBH participó en un H2020: H2020-MSCA-ITN-2015 PDZnet will create an innovative European PhD training network focusing on unraveling PDZ domain-mediated signaling networks. The emphasis w...
2016-08-10 - 2020-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.